Melanotan II (MT-2) Dosage Chart
Melanotan II is a synthetic cyclic melanocortin agonist that activates MC1R (skin pigmentation) plus MC3R, MC4R, and MC5R. It is studied for melanogenesis and, via MC4R, for appetite and sexual arousal. Research protocols use a low-dose loading phase to build pigmentation, then intermittent maintenance. Note the strong side-effect profile and the serious melanoma-monitoring caution below before anything else.
Half-life
~1-2 hours
Format
Injectable
Purity
≥98%
Protocols
3 variants
Research Protocols
Dosage Protocols
Each row reflects a common research protocol variant. These are reference ranges derived from published literature and community research — not medical guidance.
Protocol 1
Loading Protocol
Dose
0.25mg subcutaneous once daily, building toward 0.5mg
Duration
1-2 weeks, or until target pigmentation
Start low. The 0.25mg entry dose limits the nausea and flushing that hit hardest early. Pigmentation develops with UV exposure, so it is studied alongside measured sun or UV, not as a replacement for it.
Protocol 2
Maintenance Protocol
Dose
0.5-1mg subcutaneous, 2-3x per week
Duration
As needed to maintain pigmentation
Once target pigmentation is reached, frequency drops to intermittent dosing. More frequent dosing mostly adds side effects, not more tan.
Protocol 3
MC4R Overlap Note
Dose
Same doses as above
Duration
n/a
MT-2's MC4R activity is why spontaneous erections and appetite suppression occur. The refined MC4R-focused derivative studied for sexual health is PT-141 (bremelanotide); see its chart for that endpoint.
Mixing Math
Reconstitution
Reference values for preparing a research vial. Adjust the syringe reading if you change the water volume.
Vial size
10mg vial
BAC water
2ml bacteriostatic water
Concentration
5mg/ml
Dose / ml
0.25mg = 0.05ml · 0.5mg = 0.1ml
Syringe units
5 IU (0.25mg) · 10 IU (0.5mg) on a U-100 syringe
Frequently Paired
Common Stacks
Storage
Handling Notes
Lyophilized: -20°C long-term, 2-8°C short-term. Reconstituted with bacteriostatic water: refrigerate at 2-8°C and use within about 21-28 days. Swirl gently, never shake, and do not freeze the reconstituted solution.
Research Considerations
Cautions
- MELANOMA / MOLE MONITORING: MT-2 stimulates melanocytes and is linked in case reports to darkening moles, new or changing nevi, and melanoma. Get a baseline skin exam and see a dermatologist for any changing lesion. This is the single most important caution.
- Common early effects: nausea, facial flushing, appetite suppression, and spontaneous erections (MC4R). These are dose-dependent and heaviest during loading.
- Blood-pressure and heart-rate changes have been reported with central melanocortin activation.
- Melanotan II is not approved for human use in any jurisdiction. It is a research compound; source only COA-verified material.
Ready to start your research
Get Melanotan II (MT-2) from Ascension Peptides
COA-verified, US-based, discreet shipping. Use code ENHANCED for 50% off your entire order.
Buy Melanotan II (MT-2) nowResearch use only. Not medical advice. Browse all dosage charts